Enter inventor name

Francis John Ballard

This inventor holds 11 USPTO granted patents. Top assignees: Gropep Pty, Ltd., Gropep Limited, Mayo Foundation for Medical Education and Research. Active years: 1991-2006.

USPTO Granted Patents = 11

% Patents Active = 72.7

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 158(Granted Patents)

Location History:

Glenalla, AU (1991)
Glenalta, AU (1992 - 1999)
Burnside, AU (2005)
Kensington, AU (2001 - 2006)

Company Filing History:

Mayo Foundation for Medical Education and Research

patents

Years Active: 1991-2006

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7033610 - Growth-promoting agent (2006-04-25),

2. 6916790 - Treatment of osteoporosis (2005-07-12),

3. 6548482 - Treatment of osteoporosis (2003-04-15),

4. 6447808 - Growth-promoting agent (2002-09-10),

5. 6319522 - Growth-promoting agent (2001-11-20),

6. 6194208 - Modified milk growth factor (2001-02-27),

7. 5866418 - Milk protein mixture for promoting growth of animal cells or treating (1999-02-02),

8. 5679771 - Method for treating intestinal diseases (1997-10-21),

9. 5470828 - Peptide analogs of insulin-like growth factor II (1995-11-28),

10. 5164370 - Peptide analogues of insulin-like growth factor 1 (IGF-1) or factor 2 (1992-11-17),

11. 5077276 - Growth factor (1991-12-31),

Title: Francis John Ballard: Innovator in Pharmaceutical and Veterinary Compositions

Introduction

Francis John Ballard is a notable inventor based in Kensington, Australia. He has made significant contributions to the fields of pharmaceuticals and veterinary medicine, holding a total of 11 patents. His work focuses on innovative treatments for surface wounds and gastrointestinal injuries, showcasing his dedication to improving health outcomes.

Latest Patents

Among his latest patents, Ballard has developed a growth-promoting agent that relates to pharmaceutical or veterinary compositions for treating surface wounds. This invention includes methods for treating gastrointestinal injuries, diseases, or ulcers, utilizing compositions of milk product extracts that contain growth factors. Additionally, he has patented a treatment for osteoporosis, which describes a substantially pure complex including IGFIIE polypeptide and IGFBP2 polypeptide. This patent also outlines methods for targeting a compound to the skeletal extracellular matrix of a patient.

Career Highlights

Throughout his career, Ballard has worked with prominent companies such as Gropep Pty, Ltd. and Gropep Limited. His innovative spirit and commitment to research have led to advancements in medical treatments that benefit both humans and animals.

Collaborations

Ballard has collaborated with notable individuals in his field, including Geoffrey Leonard Francis and Geoffrey Owen Regester. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Francis John Ballard's contributions to pharmaceutical and veterinary compositions highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving health outcomes for both humans and animals.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]